Grant: Travel Awards - Institute Community Support
Université de Sherbrooke
$1,000.00
The role of fat-free mass in metabolic health: An opposing perspective
FY 2018-19
Summary
The metabolic syndrome (MetS) increases the risk of cardiovascular diseases and type 2 diabetes. Since fat-free mass (FFM) is a metabolically active tissue, it is generally recognized that a greater FFM has a protective effect on the risk of developing MetS. This assumption is often based on studies reporting FFM as a percentage of body weight (BW). However, recent work from our group suggests that greater absolute FFM could be deleterious to metabolic health. The objectives were thus to investigate if the conflicting results are explained by the various indices of FFM (absolute, relative to BW or relative to height). Secondly, we sought to assess the impact of FFM per se on the relative risk (RR) of MetS.
A total of 5401 individuals (46.4 ± 16.2 y; 27.5 ± 5.0 kg/m2) were included in the analyses. Absolute FFM (kg), FFM index [FFMi; (kg/m2)] and FFM% [FFM/BW *100] were determined using DXA. Quartiles were determined in a sex and age-specific fashion. The ATP III definition was used to identify individuals with MetS. The RR of having the MetS was estimated with FFMi, corrected for FM index (FMi) and physical activity (PA). The reference group for RRs was the first quartiles (Q1) of FFMi in each subgroup.
The prevalence of MetS was greater with increasing quartiles of FFM or FFMi, yet decreased with higher quartiles of FFM% (all p<0.001). Additionally, the RR of having MetS was greater compared to the reference group in all subgroups (all p<0.05), except for Q2 and Q3 in young men (p=0.347 and 0.095 respectively).
These results first suggest that the indices of FFM greatly impacts the association with MetS. Secondly, the present study suggests a greater RR of having MetS with increasing FFMi, even when corrected for FMi and PA levels. Hence, the largely purported idea that a large FFM has a protective effect against metabolic abnormalities might stem from flawed conclusions. It would, therefore, be critical to re-examine the contribution of FFM to metabolic health.
Department
Program
Travel Awards - Institute Community Support
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
400028
Name
Lagace Jean-Christophe
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Institute of Aging
Projecttitle
The role of fat-free mass in metabolic health: An opposing perspective
Programtype2
Undefined
Orgnameinp2
Université de Sherbrooke
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Composition Corporelle; Santé Métabolique; Syndrome Métabolique; Vieillissement
Abstract
The metabolic syndrome (MetS) increases the risk of cardiovascular diseases and type 2 diabetes. Since fat-free mass (FFM) is a metabolically active tissue, it is generally recognized that a greater FFM has a protective effect on the risk of developing MetS. This assumption is often based on studies reporting FFM as a percentage of body weight (BW). However, recent work from our group suggests that greater absolute FFM could be deleterious to metabolic health. The objectives were thus to investigate if the conflicting results are explained by the various indices of FFM (absolute, relative to BW or relative to height). Secondly, we sought to assess the impact of FFM per se on the relative risk (RR) of MetS.
A total of 5401 individuals (46.4 ± 16.2 y; 27.5 ± 5.0 kg/m2) were included in the analyses. Absolute FFM (kg), FFM index [FFMi; (kg/m2)] and FFM% [FFM/BW *100] were determined using DXA. Quartiles were determined in a sex and age-specific fashion. The ATP III definition was used to identify individuals with MetS. The RR of having the MetS was estimated with FFMi, corrected for FM index (FMi) and physical activity (PA). The reference group for RRs was the first quartiles (Q1) of FFMi in each subgroup.
The prevalence of MetS was greater with increasing quartiles of FFM or FFMi, yet decreased with higher quartiles of FFM% (all p<0.001). Additionally, the RR of having MetS was greater compared to the reference group in all subgroups (all p<0.05), except for Q2 and Q3 in young men (p=0.347 and 0.095 respectively).
These results first suggest that the indices of FFM greatly impacts the association with MetS. Secondly, the present study suggests a greater RR of having MetS with increasing FFMi, even when corrected for FMi and PA levels. Hence, the largely purported idea that a large FFM has a protective effect against metabolic abnormalities might stem from flawed conclusions. It would, therefore, be critical to re-examine the contribution of FFM to metabolic health.
Competitiondate
201901
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lagace, Jean-Christophe
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Aging~ $1,000~ $0~